Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP895253.RA2foL80kb0Bv5YKm3mhc2TD-TDWUt2MLu5WeOGgoJJmg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP895253.RA2foL80kb0Bv5YKm3mhc2TD-TDWUt2MLu5WeOGgoJJmg130_assertion type Assertion NP895253.RA2foL80kb0Bv5YKm3mhc2TD-TDWUt2MLu5WeOGgoJJmg130_head.
- NP895253.RA2foL80kb0Bv5YKm3mhc2TD-TDWUt2MLu5WeOGgoJJmg130_assertion description "[Nevirapine induced extensive reprogramming of gene expression in vitro with up-regulation of genes that might be silenced during prostate tumor progression (i.e., K18, PSA and androgen receptor) and down-regulation of genes involved in the progression toward an androgen-independent phenotype (i.e., K5, EGFR1, EGF and VEGF-A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP895253.RA2foL80kb0Bv5YKm3mhc2TD-TDWUt2MLu5WeOGgoJJmg130_provenance.
- NP895253.RA2foL80kb0Bv5YKm3mhc2TD-TDWUt2MLu5WeOGgoJJmg130_assertion evidence source_evidence_literature NP895253.RA2foL80kb0Bv5YKm3mhc2TD-TDWUt2MLu5WeOGgoJJmg130_provenance.
- NP895253.RA2foL80kb0Bv5YKm3mhc2TD-TDWUt2MLu5WeOGgoJJmg130_assertion SIO_000772 19152342 NP895253.RA2foL80kb0Bv5YKm3mhc2TD-TDWUt2MLu5WeOGgoJJmg130_provenance.
- NP895253.RA2foL80kb0Bv5YKm3mhc2TD-TDWUt2MLu5WeOGgoJJmg130_assertion wasDerivedFrom befree-20150227 NP895253.RA2foL80kb0Bv5YKm3mhc2TD-TDWUt2MLu5WeOGgoJJmg130_provenance.
- NP895253.RA2foL80kb0Bv5YKm3mhc2TD-TDWUt2MLu5WeOGgoJJmg130_assertion wasGeneratedBy ECO_0000203 NP895253.RA2foL80kb0Bv5YKm3mhc2TD-TDWUt2MLu5WeOGgoJJmg130_provenance.